Mirtazapine Induced Bipedal Edema: A Case Report

Authors

  • Richa Amatya Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Nepal
  • Dipak Kunwar Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Nepal
  • Barsha Shrestha Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Nepal
  • Subeskshya Khadka Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Nepal
  • Ajay Risal Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Nepal

Keywords:

Mirtazapine, Peripheral Edema, Side effect

Abstract

Mirtazapine is a commonly used antidepressant which works via alpha-2 adrenergic
antagonism to enhance noradrenergic and serotonergic neurotransmission.
There is only dearth of literature to suggest the link between mirtazapine use
and development of peripheral edema. With this article, we aim to discuss the
probability of peripheral edema during the treatment course of mirtazapine. This
is among the handful of cases reported describing the probability of peripheral
edema due to mirtazapine. Thus, it will be of utmost use to the prescribing
physician.

Downloads

Download data is not yet available.
Abstract
29
PDF
81

Author Biographies

Richa Amatya, Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Nepal

Department of Psychiatry

Dipak Kunwar, Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Nepal

Department of Psychiatry

Barsha Shrestha, Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Nepal

Department of Psychiatry

Subeskshya Khadka, Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Nepal


Department of Psychiatry

Ajay Risal, Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Nepal

Department of Psychiatry

Downloads

Published

2023-11-30

How to Cite

Amatya, R. ., Kunwar, D. ., Shrestha, B. ., Khadka, S. ., & Risal, A. . (2023). Mirtazapine Induced Bipedal Edema: A Case Report. Annapurna Journal of Health Sciences, 2(1), 46–47. Retrieved from https://nepjol.info./index.php/ajhs/article/view/58991

Issue

Vol. 2 No. 1 (2022)

Section

Case Reports

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.